41 / 102
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 3, May/June 2016
AFRICA
163
9.
Jeremy JY, Bulbulia R, Johnson JL, Gadsdon P, Vijayan V, Shukla N,
et
al
. A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits
porcine saphenous vein graft thickening.
J Thorac Cardiovasc Surg
2004;
127
: 1766–1772.
10. Stooker W, Niessen HW, Wildevuur WR, van Hinsbergh VW, Fritz J,
Jansen EK,
et al
. Perivenous application of fibrin glue reduces early
injury to the human saphenous vein graft wall in an
ex vivo
model.
Eur J
Cardiothorac Surg
2002;
21
: 212–217.
11. Wan S, Yim APC, Johnson JL, Shukla N, Angelini GD, Smith FCT,
et al
. The endothelin-1A receptor antagonist BSF 302146 is a potent
inhibitor of neointimal and medial thickening in porcine saphenous
vein-carotid artery interposition grafts.
J Thorac Cardiovasc Surg
2004;
127
: 1317–1322.
12. Shukla N, Angelini GD, Ascione R, Talpahewa S, Capoun R, Jeremy JY.
Nitric oxide donating aspirins: novel drugs for the treatment of saphen-
ous vein graft failure.
Ann Thorac Surg
2003;
75
: 1437–1442.
13. Wan S, George SJ, Nicklin SA, Yim APC, Baker AH. Overexpression
of p53 increases lumen size and blocks neointima formation in porcine
interposition vein grafts.
Mol Ther
2004;
9
: 689–698.
14. Jeremy JY, Dashwood MR. Microvascular repair. In: Shepro AM, ed.
Encyclopaedia of the Microvasculature.
Elsevier Science, 2005: 903–911.
15. Nomura H, Naito M, Iguchi A, Thompson WD, Smith EB. Fibrin gel
induces the migration of smooth muscle cells from rabbit aortic explants.
Thromb Haemost
1999;
82
: 1347–1352.
16. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH.
Syndromes of accelerated atherosclerosis: role of vascular injury and
smooth muscle cell proliferation.
J Am Coll Cardiol
1990;
15
: 1667–1687.
17. Okazaki Y, Takarabe K, Murayama J, Suenaga E, Furukawa K, Rikitake
K,
et al
. Coronary endothelial damage during off-pump CABG related
to coronary-clamping and gas insufflation.
Eur J Cardiothorac Surg
2001;
19
: 834–839.
18. Moon MC, Molnar K, Yau L, Zahradka P. Perivascular delivery of
losartan with surgical fibrin glue prevents neointimal hyperplasia after
arterial injury.
J Vasc Surg
2004;
40
: 130–137.
19. Vijayan V, Shukla N, Johnson JL, Gadsdon P, Angelini GD, Smith FC,
et al
. Long-term reduction of medial and intimal thickening in porcine
saphenous vein grafts with a polyglactin biodegradable external sheath.
J
Vasc Surg
2004;
40
: 1011–1019.
20. Del Corso A, Bargellini I, Cicorelli A, Perrone O, Leo M, Lunardi A,
et al
. Efficacy and safety of a novel vascular closure device (Glubran
2 seal) after diagnostic and interventional angiography in patients with
peripheral arterial occlusive disease.
Cardiovasc Intervent Radiol
2013;
36
(2): 371–376.
21. Kull S, Martinelli I, Briganti E, Losi P, Spiller D, Tonlorenzi S,
et al
.
Glubran 2 surgical glue:
in vitro
evaluation of adhesive and mechanical
properties.
J Surg Res
2009;
157
(1): e15–21.
22. Dai L, Gao M, Gu C, Zhang F, Yu Y. Perivenous application of
cyanoacrylate tissue sealants reduces intimal and medial thickening of
the vein graft and inflammatory responses in a rabbit model of carotid
artery bypass grafting.
Eur J Cardiothorac Surg
2015, Apr 2. pii: ezv111.
SHARE: Sustain Health development in Africa through
Responsible Education
Founded nine years ago by Prof Jean Marco (France) and
Dr Francois Bourlon (Monaco), who has been largely
instrumental in driving it, SHARE is a non-profit organisation
that provides essential training to African cath lab staff by
linking them with experienced teams in Europe, the USA and
Asia Pacific. It’s aimed at those African cardiologists who
wish to build a local diagnostic and interventional practice
and need to develop their skills.
‘Africa has 1.1 billion people in 54 countries, only 20 of
which have a cath lab’, said Dr Bourlon. ‘We therefore saw
a need for a training organisation, which is funded by the
private sector and industry partners.’
SHARE’s first initiative was the establishment of a medico-
surgical centre in Nouakchott, Mauritania, North Africa. ‘We
started fromnothing, whichmakes it a significant achievement.
The centre comprises one cath lab, two operating theatres, one
recovery room, one sterilisation unit and one in-patient unit.
With the assistance of the Europa Organisation, we have
trained four cardiologists and four allied health professionals,
who committed to return to Mauritania once their training
was finished and submit written activity reports every
three months. The unit is now autonomous, undertaking
angiography, percutaneous interventions and cardiac surgery.
It has even organised its own congress.’
Now SHARE is facilitating the training of an
interventional cardiologist in mitral valvuloplasty. He is
currently based in Morocco, further to a year of training in
Italy. ‘We’re also developing training material for nurses and
allied professionals in the form of short educational films that
will be made available on YouTube’, said Dr Bourlon.
With its Mauritanian initiative successfully completed,
SHARE has turned its attention to Mali in West Africa with
a view to duplicating the Mauritanian experience. ‘There is
currently no such facility in the capital, Bamako, so we are
looking to design and build a cath lab there. The initial steps
are under way, including one cardiologist currently being
trained in Monaco.’
SHARE’s vision for the future is to consolidate its actions
in Mauritania and Mali, and extend this vision to other
African countries. ‘We’re looking to find new training centres
in both Europe and Africa and facilitate the participation of
trained personnel in educational activities. We wish to create a
community of learners who are united in a shared experience.
We accept that progress is slow, but we keep moving forward
step by step’, concluded Dr Bourlon.
Source:
AfricaPCR 2016.